Cross-Site Scripting Vulnerability in IBM WebSphere Portal Products
CVE-2018-1416

6.1MEDIUM

Key Information:

Vendor

IBM
Status
Websphere Portal
Vendor
CVE Published:
27 February 2018

What is CVE-2018-1416?

IBM WebSphere Portal versions 7.0, 8.0, 8.5, and 9.0 have a vulnerability that permits cross-site scripting attacks. This issue enables attackers to inject arbitrary JavaScript into the Web user interface, potentially altering normal functionality and leading to unauthorized disclosure of sensitive user credentials within a trusted session. Organizations using affected versions should assess their exposure and implement security measures to mitigate the risk of exploitation.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

WebSphere Portal 7.0

WebSphere Portal 8.0

WebSphere Portal 8.5

References

https://exchange.xforce.ibmcloud.com/vulnerabilities/138822
x_refsource_MISC
http://www.ibm.com/support/docview.wss?uid=swg22013706
x_refsource_CONFIRM
http://www.securityfocus.com/bid/103168
vdb-entryx_refsource_BID

CVSS V3.1

Score:
6.1
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.